Follistatin 344 vs MGF: A Simple Research Comparison

Two Peptides, One Big Question

You've probably seen both names — Follistatin 344 and MGF — pop up in fitness forums and research blogs. They both get lumped together as "muscle peptides," but they work in completely different ways. Let's untangle them.

What Is Follistatin 344?

Follistatin 344 (FS-344) is a protein that naturally exists in your body. Its main job is to neutralize myostatin — a signaling molecule that tells your muscles to stop growing. Think of myostatin as the speed limiter on a car. Follistatin 344 removes that limiter.

The "344" refers to a specific isoform — a particular version of the follistatin protein with 344 amino acids. No pharmaceutical version of follistatin 344 has been approved for human use anywhere in the world.^[1] That hasn't stopped a black market from emerging. Researchers who analyzed gray-market products found that only 9 of 17 tested vials actually contained follistatin at all — others contained completely different peptides, including MGF itself.^[2][3]

What Is MGF?

MGF stands for Mechano Growth Factor. It's a splice variant — a differently cut version — of IGF-1 (Insulin-like Growth Factor 1). Your muscles produce it naturally when they're mechanically stressed, like during exercise. It signals local muscle cells to repair and grow.

Because it's locally acting and short-lived, researchers have been interested in whether a synthetic version could be used to accelerate muscle repair after injury.^[1] Like FS-344, no MGF product is currently approved for human therapeutic use.

How Does Research Dosing Differ?

This is where things get complicated — and where you need to read carefully. Dosing in animal studies (mostly rodents) does not translate directly to humans. Body weight, metabolism, and delivery method all change the picture dramatically.

• Follistatin 344 animal studies: Doses in rodent research have typically been administered via intramuscular injection, often in microgram-per-kilogram ranges. Human gray-market use — which is unvalidated and risky — reportedly involves doses in the range of 50–200 mcg, though these figures have no clinical backing.^[1]
• MGF animal studies: Research in rodents has used synthetic PEGylated MGF (to extend its very short half-life) at doses also in mcg/kg ranges. The half-life of unmodified MGF is only a few minutes, making dosing logistics a real research challenge.^[1]
• Route of administration: Both are typically injected subcutaneously or intramuscularly in research settings. Neither has an approved oral form.
• Frequency: FS-344 is often studied in single or limited-dose protocols because of its potency. MGF, especially PEGylated forms, is studied with more frequent dosing windows.

For a side-by-side breakdown of reported research figures, use our calculator to explore weight-adjusted comparisons based on published animal data.

Quick Comparison: FS-344 vs MGF

• Mechanism: FS-344 blocks myostatin (systemic effect); MGF signals local muscle repair (local effect)
• Origin: FS-344 is a full protein; MGF is a peptide fragment of IGF-1
• Half-life: FS-344 is relatively stable; unmodified MGF degrades in minutes
• Research focus: FS-344 — systemic muscle mass; MGF — localized injury repair
• Human data: Both have essentially none — animal models only^[1]
• Regulatory status: Both unapproved; FS-344 is explicitly banned by WADA^[2]
• Gray-market purity: FS-344 products are frequently mislabeled or contaminated^[2][3]

How to Choose What to Read About

If you're researching systemic muscle hypertrophy mechanisms — how the body regulates muscle size at a broad level — the science around Follistatin 344 and myostatin inhibition is the more relevant literature.

If you're interested in localized muscle repair after mechanical damage — think injury recovery or post-exercise signaling — then the MGF research track is more relevant to explore.

Either way, a 2026 sports medicine review makes the situation plain: many unapproved peptides show promising results in animal models, but rigorous human safety data are scarce, and there is real potential for harm.^[1] Reading the primary literature — not forum posts — is the only reliable starting point.

The Bottom Line

These are not interchangeable compounds. They act differently, have different research profiles, and carry different risks. Both remain firmly in the research-only category. Always consult the original studies, understand the animal-to-human gap, and use quality tools like our calculator to contextualize the numbers you read.

Sources

1. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. — Sports medicine (Auckland, N.Z.), 2026. PMID 41966639.
2. Detection of black market follistatin 344. — Drug testing and analysis, 2019. PMID 31758732.
3. Detection of black market follistatin 344. — Drug testing and analysis, 2020. PMID 33460286.
4. Intraoperative graft verification in coronary surgery. — Journal of cardiovascular medicine (Hagerstown, Md.), 2017. PMID 27366820.
5. Mangiferin mitigates neurological deficits and ferroptosis via NRF2/ARE pathway activation in cerebral ischemia-reperfusion rats. — Frontiers in pharmacology, 2025. PMID 40474971.
6. Mangiferin Alleviates Formaldehyde-Induced Tau Hyperphosphorylation and Cognitive Impairment in Mice via the PI3K/AKT/GSK3β Pathway: Insights From Network Pharmacology and Experimental Validation. — FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2026. PMID 41537771.